1. Home
  2. CORT vs ENLT Comparison

CORT vs ENLT Comparison

Compare CORT & ENLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$121.38

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Logo Enlight Renewable Energy Ltd.

ENLT

Enlight Renewable Energy Ltd.

N/A

Current Price

$67.38

Market Cap

9.1B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CORT
ENLT
Founded
1998
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
9.1B
IPO Year
2001
2022

Fundamental Metrics

Financial Performance
Metric
CORT
ENLT
Price
$121.38
$67.38
Analyst Decision
Buy
Hold
Analyst Count
5
8
Target Price
★ $141.00
$86.14
AVG Volume (30 Days)
★ 872.9K
144.8K
Earning Date
11-03-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.09
N/A
Revenue
★ $761,407,000.00
N/A
Revenue This Year
$50.53
$61.76
Revenue Next Year
$48.75
$41.88
P/E Ratio
$1,317.11
★ $76.10
Revenue Growth
★ 12.79
N/A
52 Week Low
$28.66
$32.75
52 Week High
$126.38
$108.65

Technical Indicators

Market Signals
Indicator
CORT
ENLT
Relative Strength Index (RSI) 59.16 40.21
Support Level $108.33 $64.64
Resistance Level $123.01 $79.81
Average True Range (ATR) 5.11 1.46
MACD 0.39 0.09
Stochastic Oscillator 83.38 27.84

Price Performance

Historical Comparison
CORT
ENLT

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

About ENLT Enlight Renewable Energy Ltd.

Enlight Renewable Energy Ltd develops, finances, constructs, owns, and operates utility-scale renewable energy projects. The company's operating segments are the MENA segment, Europe segment, U.S.A segment, and Others. It generates the majority of its revenue from the Europe segment, producing its revenue from the sale of the electricity which is produced through wind energy and solar energy in Europe.

Share on Social Networks: